nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation by synthetic lipid A subunit analogues (GLA compounds) of tumoricidal properties in human blood monocytes
|
Maeda, Hiroaki |
|
1990 |
8 |
3 |
p. 237-242 6 p. |
artikel |
2 |
Advances in virus research Vol. 34
|
Stephenson, John R. |
|
1990 |
8 |
3 |
p. 293- 1 p. |
artikel |
3 |
Calendar
|
|
|
1990 |
8 |
3 |
p. 296- 1 p. |
artikel |
4 |
Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination
|
Hirabayashi, Yoshihiro |
|
1990 |
8 |
3 |
p. 243-248 6 p. |
artikel |
5 |
Critical role of neighbouring sequences on the immunogenicity of the C3 poliovirus neutralization epitope expressed at the surface of recombinant bacteria
|
van der Werf, S. |
|
1990 |
8 |
3 |
p. 269-277 9 p. |
artikel |
6 |
Defining minimal requirements for antibody production to peptide antigens
|
Goodman-Snitkoff, Gail |
|
1990 |
8 |
3 |
p. 257-262 6 p. |
artikel |
7 |
Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines
|
Watt, P.J. |
|
1990 |
8 |
3 |
p. 231-236 6 p. |
artikel |
8 |
Development and application of an improved infectivity assay for the standardization of avian encephalomyelitis vaccines
|
Shafren, D.R. |
|
1990 |
8 |
3 |
p. 283-285 3 p. |
artikel |
9 |
EBV-related antigen expression vector and transformation of Escherichia coli — recombinant Epstein-Barr virus antigen production for potential recombinant vaccine development
|
|
|
1990 |
8 |
3 |
p. 291- 1 p. |
artikel |
10 |
Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults
|
Atmar, Robert L. |
|
1990 |
8 |
3 |
p. 217-224 8 p. |
artikel |
11 |
Fish vaccine against pathogenic bacteria containing live or killed avirulent, invasive immunogenic mutant strains of Vibrio anguillarum
|
|
|
1990 |
8 |
3 |
p. 290-291 2 p. |
artikel |
12 |
Haemophilus influenzae type b protein conjugate vaccine comprising reductive amination production of oxidized polyribosylribitol-phosphate fragment and outer membrane protein
|
|
|
1990 |
8 |
3 |
p. 290- 1 p. |
artikel |
13 |
Hepatitis A,B-combined adjuvanted vaccine containing an inactivated hepatitis A virus antigen and a recombinant hepatitis B virus surface antigen
|
|
|
1990 |
8 |
3 |
p. 292- 1 p. |
artikel |
14 |
Hepatitis A virus antigen comprising inactivated or attenuated complete particles containing RNA and/or immature empty particles, isolated from tissue culture for use as vaccine
|
|
|
1990 |
8 |
3 |
p. 292- 1 p. |
artikel |
15 |
Identification of foot-and-mouth disease virus replication in vaccinated cattle by antibodies to non-structural virus proteins
|
Berger, H.-G. |
|
1990 |
8 |
3 |
p. 213-216 4 p. |
artikel |
16 |
Immunoprotective antigenic protein against pathogenic bacteria comprises active adenylate-cyclase; mouse monoclonal antibody
|
|
|
1990 |
8 |
3 |
p. 290- 1 p. |
artikel |
17 |
In vitro characterization of Salmonella typhi mutant strains for live oral vaccines
|
Dragunsky, Evgenia M. |
|
1990 |
8 |
3 |
p. 263-268 6 p. |
artikel |
18 |
Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus
|
Mulcahy, G. |
|
1990 |
8 |
3 |
p. 249-256 8 p. |
artikel |
19 |
Molecular Genetics of the Rotaviruses
|
Cohen, Jean |
|
1990 |
8 |
3 |
p. 294-295 2 p. |
artikel |
20 |
New DNA encoding mutant form of HIV virus gp160 without endoproteolysis site and derived attenuated virus useful as AIDS recombinant vaccine
|
|
|
1990 |
8 |
3 |
p. 292- 1 p. |
artikel |
21 |
New peptide containing T-helper cell epitope of foot-and-mouth-disease virus and optionally B-lymphocyte epitope, useful in vaccine and for potentiating hormone activity
|
|
|
1990 |
8 |
3 |
p. 292- 1 p. |
artikel |
22 |
Non-immunological facets of poliovirus vaccines
|
Arya, S.C. |
|
1990 |
8 |
3 |
p. 179- 1 p. |
artikel |
23 |
Non-reverting live Shigella vaccines: Shigella flexneri having a requirement for an essential metabolite which is not available in a mammalian host
|
|
|
1990 |
8 |
3 |
p. 290- 1 p. |
artikel |
24 |
Novel nucleic acid sequence encoding p30 and B1: DNA sequence of Toxoplasma gondii which may be used in vaccine development and diagnosis; vector
|
|
|
1990 |
8 |
3 |
p. 291- 1 p. |
artikel |
25 |
Novel virus of the HIV-2 family: HIV virus-2-ST isolation; DNA sequence; potential application in AIDS diagnosis and vaccine construction
|
|
|
1990 |
8 |
3 |
p. 291-292 2 p. |
artikel |
26 |
Peptides from streptococcal M proteins used to prepare vaccines for providing protection against Streptococcus
|
|
|
1990 |
8 |
3 |
p. 292- 1 p. |
artikel |
27 |
Protection of mice inoculated with purified pertussis toxin and filamentous haemagglutinin against intracerebral challenge with live Bordetella pertussis
|
Gupta, Rajesh K. |
|
1990 |
8 |
3 |
p. 289- 1 p. |
artikel |
28 |
Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine)
|
Fujisawa, Yukio |
|
1990 |
8 |
3 |
p. 192-198 7 p. |
artikel |
29 |
Purified recombinant gag precursor of HIV virus from yeast or insect expression system, useful as AIDS vaccine
|
|
|
1990 |
8 |
3 |
p. 290- 1 p. |
artikel |
30 |
Recombination in vivo of pseudorabies vaccine strains to produce new virus strains
|
Katz, J.B. |
|
1990 |
8 |
3 |
p. 286-288 3 p. |
artikel |
31 |
Recovering protective antigens from crude Bordetella extracts by affinity chromatography on lectin containing adsorbent, useful as vaccine and diagnostic reagent
|
|
|
1990 |
8 |
3 |
p. 292- 1 p. |
artikel |
32 |
Relation between susceptibility to rubellavirus infection in pregnant women and decreased immune responsiveness
|
Coupland, Brian |
|
1990 |
8 |
3 |
p. 190-191 2 p. |
artikel |
33 |
Role of epidemiology in vaccine policy
|
Begg, Norman |
|
1990 |
8 |
3 |
p. 180-189 10 p. |
artikel |
34 |
Specific immune response in humans following rectal delivery of live typhoid vaccine
|
Forrest, Bruce D. |
|
1990 |
8 |
3 |
p. 209-212 4 p. |
artikel |
35 |
Stable Salmonella live vaccine strains with two or more attenuating mutations and any desired level of attenuation
|
Linde, K. |
|
1990 |
8 |
3 |
p. 278-282 5 p. |
artikel |
36 |
Vaccination against gonorrhoea: the potential protective effect of immunization with a synthetic peptide containing a conserved epitope of gonococcal outer membrane protein IB
|
Heckels, John E. |
|
1990 |
8 |
3 |
p. 225-230 6 p. |
artikel |
37 |
Vaccine against Bordetella pertussis infection comprises Bordetella bronchiseptica pilus subunit protein
|
|
|
1990 |
8 |
3 |
p. 291- 1 p. |
artikel |
38 |
Vaccine containing recombinant detoxified Pasteurella multocida toxin to protect against organisms producing osteolytic toxin, new DNA sequence and derived monoclonal antibody produced by hybridoma
|
|
|
1990 |
8 |
3 |
p. 291- 1 p. |
artikel |
39 |
Vaccine for HIV virus type 1 is composed of a polypeptide devoid of any epitope of gp160 generating HIV virus infection-enhancing antibodies
|
|
|
1990 |
8 |
3 |
p. 291- 1 p. |
artikel |
40 |
Vaccines
|
Spier, R.E. |
|
1990 |
8 |
3 |
p. 293-294 2 p. |
artikel |
41 |
Vaccinia recombinants expressing early bovine papilloma virus (BPV1) proteins: retardation of BPV1 tumour development
|
Meneguzzi, Guerrino |
|
1990 |
8 |
3 |
p. 199-204 6 p. |
artikel |
42 |
Yeast-derived hepatitis B vaccine in dental students. A three-year follow-up study
|
Zanetti, A.R. |
|
1990 |
8 |
3 |
p. 205-208 4 p. |
artikel |